HRS Guidelines Bundle (free trial)

Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders

Heart Rhythm Society GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1499527

Contents of this Issue

Navigation

Page 31 of 49

32 Table 5. Clinical scenarios for the management of arrhythmias in EDMD and LGMD1B Clinical scenario LGMD1B 4. A 42-year-old woman is admitted after a transient episode of sudden loss of consciousness. She has a history of ankle contractures since adolescence. Over the past 5 years, she has developed progressive muscle weakness with difficulty climbing stairs. She had an older sister with similar muscular disease and heart disease who died at age 38 years after complications of a stroke. Genetic testing revealed a missense mutation in LMNA. Her ECG revealed sinus tachycardia with a PR interval of 300 ms, incomplete RBBB, and left axis deviation. Transthoracic echocardiogram revealed left ventricle dilation with reduced function and an estimated LVEF of 40%. Ambulatory ECG recording revealed atrial tachycardia with 3:1 and 4:1 conduction. 5. A 35-year-old man with LGMD1B presents to the clinic to discuss the possibility of pacemaker placement. He was suspected to have LGMD1B when he was 15 years old, after developing proximal muscle weakness, in the absence of contractures. Genetic testing confirmed an LMNA mutation (1q11-21 locus). Since that time, he has had progressive lightheadedness. His 12-lead ECG and recent Holter monitoring are normal, and transthoracic echocardiography was unremarkable. (cont'd) Emery-Dreifuss and Limb-girdle Type 1B Muscular Dystrophy

Articles in this issue

Archives of this issue

view archives of HRS Guidelines Bundle (free trial) - Evaluation and Management of Arrhythmic Risk in Neuromuscular Disorders